Results 11 to 20 of about 420,674 (194)

Discrepancies between Antimullerian Hormone and Follicle Stimulating Hormone in Assisted Reproduction [PDF]

open access: yesObstetrics and Gynecology International, 2013
Data from 107 women undergoing their first IVF/ICSI were analyzed. Relationships between antimullerian hormone (AMH) and follicle stimulating hormone (FSH) were analyzed after dividing patients into four groups according to AMH/FSH levels.
Munawar Hussain   +3 more
doaj   +5 more sources

Antimullerian Hormone as a Serum Biomarker for Risk of Chemotherapy-Induced Amenorrhea. [PDF]

open access: yesJ Natl Cancer Inst, 2021
Abstract Antimullerian hormone (AMH) is a promising biomarker for ovarian reserve. In this study, we assessed AMH before and 1 year after initiation of adjuvant chemotherapy on National Surgical Adjuvant Breast and Bowel Project (NSABP)/NRG Oncology B-47 in female participants aged 42 years and younger (median age = 39 years).
Ruddy KJ   +13 more
europepmc   +8 more sources

The impact of age on antimullerian hormone serum level in women attending chemotherapy Unit for primary breast cancer

open access: yesMiddle East Fertility Society Journal, 2018
Objective: The aim of the study is to evaluate serum level of Anti-Mullerian Hormone in patients with primary breast cancer proposed to have chemotherapy and to study the effect age on Anti-Mullerian Hormone and menstrual cycle pattern after chemotherapy.
Hawraa Talib Al-Janabi   +2 more
doaj   +2 more sources

Antimullerian Hormone Levels in Premenopausal Systemic lupus Erythematosus Patients [PDF]

open access: yesZagazig University Medical Journal, 2020
Background: The use of antimullerian hormone (AMH) as a marker of ovarian reserve may contribute to treatment decisions regarding the use of medications with known gonadotoxic effects.
iman kandil   +3 more
doaj   +2 more sources

Relation of antimullerian hormone with the clinical signs of hyperandrogenism and polycystic ovary morphology

open access: yesGynecological Endocrinology, 2013
The relation of antimullerian hormone (AMH) levels with the clinical and biochemical markers of polycystic ovary syndrome (PCOS) could be different. A total of 463 PCOS patients were evaluated in this cross-sectional study. Groups were constructed according to polycystic ovarian morphology (PCOM) and menstrual cycle-length.
Sahmay, Sezai   +4 more
openaire   +3 more sources

Ultrasound in evaluating ovarian reserve

open access: yesThe Egyptian Journal of Radiology and Nuclear Medicine, 2015
The objective of this study was to compare the diagnostic accuracy of transvaginal ultrasound (TVS), as a less invasive technique instead of hormonal assay to evaluate the ovarian reserve.
Eman Ahmaed Shawky Sabek   +2 more
doaj   +2 more sources

The role of antimullerian hormone in assessing ovarian damage from chemotherapy, radiotherapy and surgery. [PDF]

open access: yesCurr Opin Endocrinol Diabetes Obes, 2018
Purpose of reviewIatrogenic ovarian damage can occur after chemotherapy, radiotherapy and surgery for cancer as well as for non-malignant conditions. This review describes the effects of such treatment on antimullerian hormone (AMH) and the implications of the fall in AMH in relation to ovarian function and fertility, especially in the era of improved ...
Wong QHY, Anderson RA.
europepmc   +7 more sources

The combined use of antimullerian hormone and age to predict the ovarian response to controlled ovarian hyperstimulation in poor responders: A novel approach

open access: yesJournal of Human Reproductive Sciences, 2013
Context: Reduced ovarian response to stimulation represents one of the most intractable problems in infertility treatment. As failed cycle can cause considerable amount of emotional and economical loss, there are various attempts made to predict ovarian ...
Yadava Bapurao Jeve
doaj   +2 more sources

[Two immunoassays for antimullerian hormone measurement: analytical and clinical performances].

open access: yesAnnales de biologie clinique, 1970
Today, serum antimullerian hormone (AMH) is considered as an interesting marker of fertility potential in women to determine follicular status and in men to evaluate testicular function. We study analytical and clinical characteristics of two AMH commercialized immunoassays: Immunotech and DSL methods.
Taieb, J.   +5 more
openaire   +3 more sources

The relationship of antimullerian hormone with severity of clinical symptoms in polycystic ovary syndrome. [PDF]

open access: yesBMC Womens Health
Abstract Background:Polycystic ovary syndrome (PCOS) is an endocrine disorder prevalent in around 6-8% of women in their reproductive years. The measurement of Anti-Müllerian Hormone (AMH) holds particular promise in discerning both the diagnosis and the extent of severity in PCOS cases.
Ata C   +5 more
europepmc   +3 more sources

Home - About - Disclaimer - Privacy